Genie Pharma, shareholder of Mengke Pharmaceutical (688373.SH), publicly solicited voting rights to oppose part of the bill

Zhitongcaijing · 09/24/2025 14:41

According to the Zhitong Finance App, Mengke Pharmaceutical (688373.SH) issued an announcement. Genie Pharma, the company's shareholder, voted against various proposals considered by the company's 2025 Second Extraordinary General Meeting of Shareholders. Genie Pharma holds a total of 71.572,800 shares of the company, accounting for 10.92% of the company's total shares. The voting period starts and ends from September 25, 2025 to October 6, 2025. The reasons for the objections of the solicitors include uncertainty about Sea Whale Pharmaceutical's participation in fixed capital increases, the risk of confusion between sales channels and personnel, the progress of the fund-raising project falling short of expectations, uncertainty about using Sea Whale Pharmaceutical's production capacity to increase profitability, and the lack of synergy in the R&D field.